Browsing: Weight Loss

GLP-1 Analogues Market to Reach US$ 299.08 Billion by 2033 as Press release 1 Analogues Market to Reach US$ 299.08 Billion by 2033 as Obesity, Diabetes and Chronic Weight Management Reshape Metabolic Care 07-09-2026 06:28 PM CET | Business, Economy, Finances, Banking & InsurancePress release from: DataM intelligence 4 Market Research LLP The global glucagon-like…

Eli Lilly shares remain near all-time highs as booming Mounjaro and Zepbound demand, global obesity-market growth, and bullish analyst targets keep the trillion-dollar pharma stock in focus

Some 90 percent of Americans have at least one risk factor for cardiovascular-kidney-metabolic – or CKM – syndrome, a term for potentially life-threatening conditions that are all connected

‘New Story’ examines the misuse of obesity treatment drugs spreading for cosmetic purposes

Genetic engineering and weight-loss innovation have become focal points for modern healthcare investors. Choosing between CRISPR Therapeutics AG (NASDAQ:CRSP) and Viking Therapeutics (NASDAQ:VKTX) depends on your appetite for risk and your belief in their distinct medical breakthroughs

Sam’s Club has partnered with Weight Watchers on new membership benefits, including a program that provides medical support to GLP-1 users

The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation

This is a paid press release. Contact the press release distributor directly with any inquiries.

Body dissatisfaction and weight concern are rampant in the United States. Research suggests that almost half of American adolescents are dissatisfied with their body. By adulthood, it’s more common for women to be dissatisfied with the way they look than satisfied (National Eating Disorders Association)

Beyond their stunning success in weight loss, drugs like Ozempic and Wegovy have been hailed by some users as having made their lives happier and improving their mental health